Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.

Parker MJ, Xue S, Alexander JJ, Wasserfall CH, Campbell-Thompson ML, Battaglia M, Gregori S, Mathews CE, Song S, Troutt M, Eisenbeis S, Williams J, Schatz DA, Haller MJ, Atkinson MA.

Diabetes. 2009 Oct;58(10):2277-84. doi: 10.2337/db09-0557. Epub 2009 Jul 23.

2.

The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.

Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, Buckner JH.

J Immunol. 2008 Nov 15;181(10):7350-5.

3.

Autologous umbilical cord blood infusion for type 1 diabetes.

Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA.

Exp Hematol. 2008 Jun;36(6):710-5. doi: 10.1016/j.exphem.2008.01.009. Epub 2008 Mar 20. Review.

4.

Treg in type 1 diabetes.

Brusko T, Atkinson M.

Cell Biochem Biophys. 2007;48(2-3):165-75. Review.

PMID:
17709886
5.

No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.

Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, Haller M, Rockell J, Gottlieb P, Clare-Salzler M, Atkinson M.

Diabetes. 2007 Mar;56(3):604-12.

6.

Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.

Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA.

Diabetes. 2005 May;54(5):1407-14.

Supplemental Content

Support Center